title: Bispecific antibodies and ADCs: Once and future kings?
authors.forename: Janice M
authors.initials: JM
authors.lastname: Reichert
mesh_terms: D000617:Aminoglycosides / Q000276:immunology / Q000627:therapeutic use; D018033:Antibodies, Bispecific / Q000276:immunology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000276:immunology / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000276:immunology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D000079982:Gemtuzumab; D006801:Humans; D018796:Immunoconjugates / Q000276:immunology / Q000627:therapeutic use*; D007167:Immunotherapy / Q000639:trends*; D009369:Neoplasms / Q000628:therapy*
chemical_list: D000617:Aminoglycosides; D018033:Antibodies, Bispecific; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D018796:Immunoconjugates; D000079982:Gemtuzumab